Ryanodine Receptor Type 2 Is Required for the Development of Pressure Overload-Induced Cardiac Hypertrophy
Open Access
- 1 December 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 58 (6), 1099-1110
- https://doi.org/10.1161/hypertensionaha.111.173500
Abstract
Ryanodine receptor type 2 (RyR-2) mediates Ca 2+ release from sarcoplasmic reticulum and contributes to myocardial contractile function. However, the role of RyR-2 in the development of cardiac hypertrophy is not completely understood. Here, mice with or without reduction of RyR-2 gene ( RyR-2 +/− and wild-type, respectively) were analyzed. At baseline, there was no difference in morphology of cardiomyocyte and heart and cardiac contractility between RyR-2 +/− and wild-type mice, although Ca 2+ release from sarcoplasmic reticulum was impaired in isolated RyR-2 +/− cardiomyocytes. During a 3-week period of pressure overload, which was induced by constriction of transverse aorta, isolated RyR-2 +/− cardiomyocytes displayed more reduction of Ca 2+ transient amplitude, rate of an increase in intracellular Ca 2+ concentration during systole, and percentile of fractional shortening, and hearts of RyR-2 +/− mice displayed less compensated hypertrophy, fibrosis, and contractility; more apoptosis with less autophagy of cardiomyocytes; and similar decrease of angiogenesis as compared with wild-type ones. Moreover, constriction of transverse aorta-induced increases in the activation of calcineurin, extracellular signal-regulated protein kinases, and protein kinase B/Akt but not that of Ca 2+ /calmodulin-dependent protein kinase II, and its downstream targets in the heart of wild-type mice were abolished in the RyR-2 +/− one, suggesting that RyR-2 is a regulator of calcineurin, extracellular signal-regulated protein kinases, and Akt but not of calmodulin-dependent protein kinase II activation during pressure overload. Taken together, our data indicate that RyR-2 contributes to the development of cardiac hypertrophy and adaptation of cardiac function during pressure overload through regulation of the sarcoplasmic reticulum Ca 2+ release; activation of calcineurin, extracellular signal-regulated protein kinases, and Akt; and cardiomyocyte survival.Keywords
This publication has 38 references indexed in Scilit:
- Accelerated Development of Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction in an RyR2-R176Q Knockin Mouse ModelHypertension, 2010
- Autophagy in Load-Induced Heart DiseaseCirculation Research, 2008
- Does Contractile Ca 2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes?Science Signaling, 2008
- Cardiac growth and angiogenesis coordinated by intertissue interactionsJCI Insight, 2007
- Myocardial Angiogenesis: Its Absence Makes the Growing Heart FounderCell Metabolism, 2007
- Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathyProceedings of the National Academy of Sciences of the United States of America, 2006
- Dichotomy of Ca2+ in the heart: contraction versus intracellular signalingJCI Insight, 2006
- The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac diseaseExpert Opinion on Investigational Drugs, 2004
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- Sodium calcium exchanger plays a key role in alteration of cardiac function in response to pressure overloadThe FASEB Journal, 2002